Search for Clinical Trial Results
Adenocarcinoma, Clear Cell - 25 Studies Found
| Status | Study |
| Active, not recruiting |
Study Name: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Condition:
|
| Withdrawn |
Study Name: Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) Condition:
|
| Completed |
Study Name: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Condition:
|
| Completed |
Study Name: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition:
|
| Completed |
Study Name: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition:
|
| Completed |
Study Name: Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol Condition:
|
| Not yet recruiting |
Study Name: Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment Condition: Clear Cell Renal Carcinoma Date: 2017-02-23 Interventions: Drug: Sunitinib Sunitinib 50 mg/d |
| Completed |
Study Name: Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer Condition:
|